Catalyst Pharmaceutical
CPRX
CPRX
135 hedge funds and large institutions have $222M invested in Catalyst Pharmaceutical in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 50 reducing their positions, and 23 closing their positions.
Holders
135
Holders Change
-7
Holders Change %
-4.93%
% of All Funds
2.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
40
Reduced
50
Closed
23
Calls
$233K
Puts
$313K
Net Calls
-$80K
Net Calls Change
-$610K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$19.3M |
| 2 |
2
Goldman Sachs
New York
|
$10.8M |
| 3 |
RA
3
Royce & Associates
New York
|
$8.03M |
| 4 |
4
Nuveen Asset Management
Chicago,
Illinois
|
$3.06M |
| 5 |
5
Millennium Management
New York
|
$1.46M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
LPL Financial
San Diego,
California
| – | -$30K | -10,000 | Closed |
|
|
GT
152
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$7K | -2,414 | Closed |
|
|
PWM
153
Provident Wealth Management
Brentwood,
Tennessee
| – | -$4K | -1,250 | Closed |
|
|
PHK
154
Point72 Hong Kong
Hong Kong
| – | -$2K | -565 | Closed |
|
|
ASN
155
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -400 | Closed |
|
|
CHAM
156
Clear Harbor Asset Management
Stamford,
Connecticut
| – | -$446 | -150 | Closed |
|